DMAC DiaMedica Therapeutics Inc. - Common Stock
NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 10, 2026
$8.23
· % 处于52周区间
· 高于低点
· 至高点
$5.2552周低点
$10.2052周高点
市值 (MRQ)
$444M
DMAC 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$8.23
市值 (MRQ)
$444M
ROE
-78.7%
52周区间
$5–$10
DMAC 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
股票拆分
| 除息日 | 拆股 | 类型 |
|---|---|---|
| 2018年11月15日 | 1-for-20 | 反向 |
10年表现 收入、净利润、利润率和每股收益趋势
收入·2018-12-31 → 2018-12-31
自由现金流$-29M2018-12-31 → 2025-12-31
净利率·2018-12-31 → 2018-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | DMAC | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 市净率 (MRQ) | 11.65年均值 ≈3.8 | ≈3.8 | 2.7 | 估值过高 | |
| 股价/自由现金流 (TTM) | -14.15年均值 ≈-8.5 | ≈-8.5 | · | · | |
| 市现率 (TTM) | -14.15年均值 ≈-8.5 | ≈-8.5 | · | · | |
| Price / Tangible Book (市净率（有形资产）) | 7.95年均值 ≈3.8 | ≈3.8 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | DMAC | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| ROA | -60.8%5年均值 ≈-44.9% | ≈-44.9% | -39.0% | 弱 | |
| ROE | -78.7%5年均值 ≈-48.2% | ≈-48.2% | -52.6% | 弱 | |
| ROIC | -61.4%5年均值 ≈-48.8% | ≈-48.8% | -34.0% | 弱 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | DMAC | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 6.75年均值 ≈17.0 | ≈17.0 | 7.9 | 持平 | |
| 速动比率 (MRQ) | 6.65年均值 ≈16.9 | ≈16.9 | 1.7 | 流动性强 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
此比率组尚无数据
基本面数据不足，尚无法计算此比率组。
资本效率 资产周转率、库存周转率、应收账款周转率
此比率组尚无数据
基本面数据不足，尚无法计算此比率组。
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
2.3%
下次报告
十一月 10, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 12, 2026 | $-0.19 | $-0.20 | 6.9% |
| 2026年3月31日 | 五月 11, 2026 | $-0.19 | $-0.19 | -0.69% |
| 2025年12月31日 | $-0.17 | $-0.18 | 7.4% | |
| 2025年9月30日 | $-0.17 | $-0.16 | -4.2% | |
| 2025年6月30日 | $-0.18 | $-0.19 | 7.1% | |
| 2025年3月31日 | $-0.18 | $-0.18 | 2.0% | |
| 2024年12月31日 | $-0.18 | $-0.18 | -2.3% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | $500.0K | |
| R&D Expense | $25M | $19M | $13M | $8M | $9M | $8M | $8M | $5M | |
| SG&A Expense | $10M | $8M | $8M | $6M | $5M | $4M | $4M | $3M | |
| Operating Expenses | $34M | $27M | $21M | $14M | $14M | $13M | $12M | $7M | |
| Operating Income | $-34M | $-27M | $-21M | $-14M | $-14M | $-13M | $-12M | $-7M | |
| Interest Income | $2M | $2M | $2M | · | · | · | · | · | |
| Other Non-op | $2M | $2M | $2M | $353.0K | $82.0K | $229.0K | $119.0K | $-68.0K | |
| Pretax Income | $-33M | $-24M | $-19M | $-14M | $-14M | $-12M | $-11M | $-6M | |
| Income Tax | $28.0K | $30.0K | $43.0K | $28.0K | $28.0K | $27.0K | $31.0K | $80.0K | |
| Net Income | $-33M | $-24M | $-19M | $-14M | $-14M | $-12M | $-11M | $-6M | |
| EPS (Basic) | $-0.70 | $-0.60 | $-0.60 | $-0.52 | $-0.65 | · | · | · | |
| Shares (Basic) | 46,980,777 | 40,404,681 | 32,566,723 | 26,443,067 | 20,773,399 | · | · | · | |
| EBITDA | $-34M | $-27M | $-21M | $-14M | $-14M | · | $-12M | $-7M |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16M | $3M | $5M | $5M | $5M | $7M | $4M | $17M | |
| Short-term Investments | $44M | $41M | $48M | $29M | $40M | $20M | $4M | · | |
| Receivables | $258.0K | $236.0K | $369.0K | $82.0K | $130.0K | $340.0K | $823.0K | $780.0K | |
| Prepaid Expense | $481.0K | $227.0K | $411.0K | $251.0K | $197.0K | $64.0K | $47.0K | $369.0K | |
| Current Assets | $61M | $45M | $54M | $34M | $45M | $28M | $9M | $18M | |
| PP&E (Net) | $145.0K | $148.0K | $131.0K | $136.0K | $70.0K | $74.0K | $64.0K | $96.0K | |
| PP&E (Gross) | $295.0K | $262.0K | $231.0K | $216.0K | $137.0K | $131.0K | $107.0K | $120.0K | |
| Accum. Depreciation | $150.0K | $114.0K | $100.0K | $80.0K | $67.0K | $57.0K | $43.0K | $24.0K | |
| Total Assets | $61M | $46M | $54M | $34M | $46M | $28M | $9M | $18M | |
| Accounts Payable | $1M | $940.0K | $926.0K | $734.0K | $509.0K | $1M | $182.0K | $483.0K | |
| Accrued Liabilities | $4M | $4M | $2M | $1M | $966.0K | $864.0K | $1M | $808.0K | |
| Current Liabilities | $5M | $5M | $3M | $2M | $2M | $2M | $1M | $1M | |
| Capital Leases | $124.0K | $225.0K | $316.0K | $396.0K | $3.0K | $46.0K | $105.0K | · | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | · | · | |
| Paid-in Capital | $229M | $181M | $167M | $128M | $127M | $95M | $64M | $63M | |
| Retained Earnings | $-173M | $-140M | $-116M | $-96M | $-83M | $-69M | $-57M | $-46M | |
| AOCI | $50.0K | $23.0K | $6.0K | $-74.0K | $-51.0K | $-2.0K | $2.0K | · | |
| Stockholders' Equity | $56M | $41M | $51M | $32M | $44M | $26M | $8M | $17M | |
| Liabilities + Equity | $61M | $46M | $54M | $34M | $46M | $28M | $9M | $18M | |
| Shares Outstanding | 53,742,370 | 42,818,660 | 37,958,000 | 26,443,067 | 26,443,067 | 18,746,157 | 12,006,874 | 11,956,874 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $2M | $2M | $2M | $2M | $2M | $1M | $620.0K | |
| Deferred Tax | $0 | $0 | · | · | · | · | · | · | |
| Operating Cash Flow | $-29M | $-22M | $-19M | $-12M | $-12M | $-9M | $-9M | $-6M | |
| CapEx | $40.0K | $25.0K | $24.0K | $81.0K | $22.0K | $47.0K | $2.0K | $50.0K | |
| Investing Cash Flow | $-2M | $9M | $-18M | $12M | $-21M | $-16M | $-4M | $-50.0K | |
| Stock Issued | $43M | $12M | $37M | $0 | $30M | $29M | · | $15M | |
| Net Stock Activity | $43M | $12M | $37M | $0 | $30M | · | · | $15M | |
| Financing Cash Flow | $44M | $12M | $37M | $-6.0K | $30M | $29M | $70.0K | $21M | |
| Net Change in Cash | $13M | $-2M | $-185.0K | $21.0K | $-3M | $4M | $-13M | $15M | |
| Free Cash Flow | $-29M | $-22M | $-19M | $-12M | $-12M | · | $-9M | $-6M |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | -1352.2% | |
| Net Margin | · | · | · | · | · | · | · | -1146.8% | |
| Pretax Margin | · | · | · | · | · | · | · | -1130.8% | |
| EBITDA Margin | · | · | · | · | · | · | · | -1352.2% | |
| ROA | -60.8% | -48.6% | -43.8% | -34.2% | -36.9% | · | -77.8% | -56.9% | |
| ROE | -78.7% | -55.1% | -36.3% | -40.9% | -29.8% | · | -123.0% | -54.3% | |
| ROIC | -61.4% | -65.6% | -41.8% | -44.1% | -31.1% | · | -152.6% | -40.3% |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.8 | 8.3 | 19.3 | 15.6 | 29.8 | · | 6.7 | 13.9 | |
| Quick Ratio | 11.7 | 8.2 | 19.1 | 15.5 | 29.7 | · | 6.6 | 13.6 |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | 1.2 |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.04 | $0.95 | $1.35 | $1.20 | $1.66 | · | $0.63 | $1.42 | |
| Cash / Share | $0.29 | $0.07 | $0.12 | $0.18 | $0.18 | · | $0.32 | $1.41 |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | $500.0K | |
| Net Income TTM | $-33M | $-24M | $-19M | $-14M | $-14M | $-12M | $-11M | $-6M | |
| Market Cap | $428M | $233M | $108M | $42M | $99M | · | $58M | $35M | |
| P/S | · | · | · | · | · | · | · | 69.6 | |
| P/B | 7.6 | 5.7 | 2.1 | 1.3 | 2.2 | · | 7.6 | 2.0 | |
| P / Tangible Book | 7.6 | 5.7 | 2.1 | 1.3 | 2.2 | 7.3 | · | · | |
| P / Cash Flow | -14.7 | -10.5 | -5.8 | -3.6 | -8.1 | · | -6.4 | -6.1 | |
| P / FCF | -14.7 | -10.5 | -5.7 | -3.6 | -8.0 | · | -6.4 | -6.1 |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $8M | $8M | $7M | $6M | $6M | $6M | $6M | $5M | $4M | $4M | $4M | $3M | $3M | $4M | $2M | $2M | |
| SG&A Expense | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | |
| Operating Income | $-10M | $-10M | $-9M | $-9M | $-8M | $-8M | $-8M | $-7M | $-6M | $-6M | $-6M | $-5M | $-5M | $-6M | $-4M | $-3M | |
| Interest Income | · | $470.0K | $472.0K | $440.0K | $313.0K | $444.0K | $543.0K | $618.0K | $524.0K | $616.0K | · | · | · | · | · | · | |
| Other Non-op | $366.0K | $447.0K | $1M | $-21.0K | $314.0K | $443.0K | $2M | $-2.0K | $2.0K | $597.0K | $709.0K | $693.0K | $271.0K | $256.0K | $229.0K | $76.0K | |
| Pretax Income | $-10M | $-10M | $-9M | $-9M | $-8M | $-8M | $-8M | $-6M | $-5M | $-5M | $-5M | $-4M | $-4M | $-5M | $-4M | $-3M | |
| Income Tax | $7.0K | $7.0K | $10.0K | $6.0K | $6.0K | $6.0K | $9.0K | $7.0K | $7.0K | $7.0K | $22.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | |
| Net Income | $-10M | $-10M | $-9M | $-9M | $-8M | $-8M | $-8M | $-6M | $-5M | $-5M | $-5M | $-4M | $-4M | $-5M | $-4M | $-3M | |
| EPS (Basic) | $-0.19 | $-0.19 | $-0.17 | $-0.17 | $-0.18 | $-0.18 | $-0.18 | $-0.15 | $-0.13 | $-0.14 | $-0.12 | $-0.12 | $-0.16 | $-0.20 | $-0.14 | $-0.12 | |
| Shares (Basic) | 53,894,295 | 53,793,490 | · | 49,630,119 | 42,957,619 | 42,843,938 | · | 42,751,577 | 38,068,378 | 37,958,000 | · | 37,949,422 | 27,312,008 | 26,448,941 | · | 26,443,067 | |
| EBITDA | $-10M | $-10M | · | $-9M | $-8M | $-8M | · | $-7M | $-6M | $-6M | · | $-5M | $-5M | $-6M | · | $-3M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $5M | $16M | $3M | $4M | $3M | $3M | $4M | $14M | $2M | $5M | $2M | $6M | $2M | $5M | $3M | |
| Short-term Investments | $38M | $46M | $44M | $52M | $26M | $34M | $41M | $46M | $40M | $44M | $48M | $44M | $35M | $27M | $29M | $33M | |
| Receivables | $244.0K | $301.0K | $258.0K | $260.0K | $161.0K | $253.0K | $236.0K | $290.0K | $391.0K | $399.0K | $369.0K | $310.0K | $188.0K | $57.0K | $82.0K | $75.0K | |
| Prepaid Expense | $567.0K | $731.0K | $481.0K | $445.0K | $680.0K | $649.0K | $227.0K | $280.0K | $568.0K | $569.0K | $411.0K | $1M | $675.0K | $962.0K | $251.0K | $322.0K | |
| Current Assets | $44M | $52M | $61M | $56M | $31M | $37M | $45M | $51M | $55M | $47M | $54M | $48M | $41M | $30M | $34M | $36M | |
| PP&E (Net) | $133.0K | $142.0K | $145.0K | $150.0K | $152.0K | $149.0K | $148.0K | $151.0K | $152.0K | $132.0K | $131.0K | $135.0K | $133.0K | $136.0K | $136.0K | $110.0K | |
| PP&E (Gross) | $297.0K | $301.0K | $295.0K | $289.0K | $280.0K | $271.0K | $262.0K | $254.0K | $250.0K | $238.0K | $231.0K | $232.0K | $222.0K | $219.0K | $216.0K | $183.0K | |
| Accum. Depreciation | $164.0K | $159.0K | $150.0K | $139.0K | $128.0K | $122.0K | $114.0K | $103.0K | $98.0K | $106.0K | $100.0K | $97.0K | $89.0K | $83.0K | $80.0K | $73.0K | |
| Total Assets | $45M | $53M | $61M | $57M | $31M | $39M | $46M | $53M | $57M | $49M | $54M | $58M | $62M | $30M | $34M | $37M | |
| Accounts Payable | $3M | $3M | $1M | $2M | $1M | $2M | $940.0K | $1M | $759.0K | $716.0K | $926.0K | $863.0K | $856.0K | $2M | $734.0K | $864.0K | |
| Accrued Liabilities | $4M | $2M | $4M | $3M | $3M | $3M | $4M | $3M | $2M | $2M | $2M | $1M | $1M | $956.0K | $1M | $637.0K | |
| Current Liabilities | $7M | $6M | $5M | $5M | $4M | $5M | $5M | $4M | $3M | $3M | $3M | $2M | $2M | $3M | $2M | $2M | |
| Capital Leases | $69.0K | $96.0K | $124.0K | $150.0K | $176.0K | $201.0K | $225.0K | $249.0K | $272.0K | $294.0K | $316.0K | $337.0K | $4.0K | $4.0K | $396.0K | $415.0K | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Paid-in Capital | $231M | $230M | $229M | $216M | $183M | $182M | $181M | $180M | $179M | $167M | $167M | $166M | $166M | $128M | $128M | $128M | |
| Retained Earnings | $-193M | $-183M | $-173M | $-164M | $-155M | $-148M | $-140M | $-132M | $-126M | $-121M | $-116M | $-110M | $-106M | $-101M | $-96M | $-92M | |
| AOCI | $-37.0K | $-26.0K | $50.0K | $50.0K | $-14.0K | $5.0K | $23.0K | $81.0K | $-51.0K | $-39.0K | $6.0K | $-127.0K | $-63.0K | $-29.0K | $-74.0K | $-162.0K | |
| Stockholders' Equity | $38M | $47M | $56M | $52M | $27M | $34M | $41M | $48M | $53M | $46M | $51M | $56M | $60M | $27M | $32M | $35M | |
| Liabilities + Equity | $45M | $53M | $61M | $57M | $31M | $39M | $46M | $53M | $57M | $49M | $54M | $58M | $62M | $30M | $34M | $37M | |
| Shares Outstanding | 53,925,697 | 53,883,345 | 53,742,370 | 52,077,439 | 43,072,488 | 42,859,465 | 42,818,660 | 42,766,497 | 42,692,582 | 37,963,916 | 37,958,000 | 37,953,711 | 37,949,422 | 26,464,977 | 26,443,067 | 26,443,067 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $822.0K | $1M | $1M | $771.0K | $867.0K | $589.0K | $565.0K | $443.0K | $488.0K | $456.0K | $425.0K | $380.0K | $422.0K | $411.0K | $418.0K | |
| Operating Cash Flow | $-8M | $-9M | $-8M | $-7M | $-8M | $-7M | $-6M | $-4M | $-5M | $-7M | $-4M | $-5M | $-5M | $-5M | $-3M | $-2M | |
| CapEx | $3.0K | $8.0K | $6.0K | $16.0K | $6.0K | $12.0K | $7.0K | $9.0K | $0 | $9.0K | $3.0K | $10.0K | $4.0K | $7.0K | $32.0K | $43.0K | |
| Investing Cash Flow | $8M | $-2M | $8M | $-26M | $9M | $7M | $5M | $-6M | $5M | $4M | $6M | $1M | $-28M | $3M | $5M | $2M | |
| Stock Issued | · | · | $12M | $32M | · | · | $0 | $0 | · | · | $0 | $-4.0K | · | · | $0 | $0 | |
| Financing Cash Flow | $132.0K | $417.0K | $12M | $32M | $161.0K | $91.0K | $120.0K | $123.0K | $12M | $-1.0K | $-1.0K | $-6.0K | $37M | $-1.0K | $-1.0K | $-2.0K | |
| Net Change in Cash | $261.0K | $-11M | $12M | $-783.0K | $2M | $-436.0K | $-1M | $-10M | $12M | $-2M | $2M | $-4M | $4M | $-3M | $2M | $-291.0K | |
| Free Cash Flow | · | $-9M | · | · | · | $-7M | · | · | · | $-7M | · | · | · | $-5M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -26.5% | -21.9% | · | -15.7% | -17.4% | -17.5% | · | -11.3% | -8.6% | -13.0% | · | -9.4% | -8.8% | -14.6% | · | -7.1% | |
| ROE | -30.9% | -24.7% | · | -17.3% | -19.1% | -19.2% | · | -12.1% | -9.0% | -14.0% | · | -9.9% | -9.2% | -15.6% | · | -7.4% | |
| ROIC | -27.4% | -22.2% | · | -17.5% | -29.5% | -24.0% | · | -14.4% | -10.6% | -12.4% | · | -9.3% | -8.0% | -20.5% | · | -8.9% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.7 | 9.1 | · | 10.7 | 7.6 | 8.0 | · | 11.8 | 17.8 | 18.1 | · | 22.1 | 21.2 | 10.5 | · | 23.7 | |
| Quick Ratio | 6.6 | 9.0 | · | 10.6 | 7.3 | 7.8 | · | 11.7 | 17.6 | 17.9 | · | 21.6 | 20.8 | 10.2 | · | 23.4 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.71 | $0.88 | · | $0.99 | $0.63 | $0.79 | · | $1.12 | $1.25 | $1.22 | · | $1.47 | $1.57 | $1.02 | · | $1.33 | |
| Cash / Share | $0.10 | $0.09 | · | $0.06 | $0.10 | $0.06 | · | $0.10 | $0.33 | $0.06 | · | $0.06 | $0.15 | $0.08 | · | $0.10 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-38M | $-35M | · | $-32M | $-30M | $-27M | · | $-22M | $-20M | $-19M | · | $-18M | $-17M | $-15M | · | $-13M | |
| Market Cap | $380M | $365M | · | $358M | $168M | $162M | · | $179M | $126M | $105M | · | $98M | $164M | $40M | · | $33M | |
| P/B | 9.9 | 7.7 | · | 6.9 | 6.2 | 4.8 | · | 3.7 | 2.4 | 2.3 | · | 1.8 | 2.7 | 1.5 | · | 0.9 | |
| P / Tangible Book | 9.9 | 7.7 | · | 6.9 | 6.2 | 4.8 | · | 3.7 | 2.4 | 2.3 | · | 1.8 | 2.7 | 1.5 | · | 0.9 | |
| P / Cash Flow | · | -40.2 | · | · | · | -22.7 | · | · | · | -15.8 | · | · | · | -8.0 | · | · |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 净收入 | $-33M | $-24M | $-19M | $-14M | $-14M |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 11.8 | 8.3 | 19.3 | 15.6 | 29.8 |
| 速动比率 | 11.7 | 8.2 | 19.1 | 15.5 | 29.7 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-29M | $-22M | $-19M | $-12M | $-12M |
机构持有人 (13F) 90 家申报者 · $98.5M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
90
持有价值
$98.5M
新仓位
11
已退出持仓
19
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 11 (-10 与上一季度对比) | 19 (+8 与上一季度对比) | 32 (+4 与上一季度对比) | 18 (-7 与上一季度对比) | +725K |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| COOPERMAN LEON G | $24288000 | 3450000 | 24.65% | 股份 |
| BlackRock, Inc. | $15856086 | 2252285 | 16.10% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $6296035 | 894115 | 6.39% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $5950975 | 845309 | 6.04% | 股份 |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | $5923750 | 875000 | 6.01% | 股份 |
| VANGUARD GROUP INC | $5756035 | 723120 | 5.84% | 股份 |
| STATE STREET CORP | $4553071 | 646743 | 4.62% | 股份 |
| Bleichroeder LP | $2691512 | 382317 | 2.73% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $2502882 | 355523 | 2.54% | 股份 |
| OSAIC HOLDINGS, INC. | $2380261 | 338107 | 2.42% | 股份 |
| NORTHERN TRUST CORP | $2305727 | 327518 | 2.34% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1771764 | 251671 | 1.80% | 股份 |
| LPL Financial LLC | $1643840 | 233500 | 1.67% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $1460364 | 207438 | 1.48% | 股份 |
| GOLDMAN SACHS GROUP INC | $1183185 | 168066 | 1.20% | 股份 |
| CITADEL ADVISORS LLC | $1026925 | 145870 | 1.04% | 股份 |
| Squarepoint Ops LLC | $1022539 | 145247 | 1.04% | 股份 |
| Bank of New York Mellon Corp | $829449 | 117820 | 0.84% | 股份 |
| MEMBERS WEALTH LLC | $713729 | 101382 | 0.72% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $680705 | 96691 | 0.69% | 股份 |
| COBALT CAPITAL MANAGEMENT, INC. | $633600 | 90000 | 0.64% | 股份 |
| Trexquant Investment LP | $595922 | 84648 | 0.60% | 股份 |
| MAGNOLIA CAPITAL ADVISORS LLC | $544931 | 77405 | 0.55% | 股份 |
| Diametric Capital, LP | $539411 | 76621 | 0.55% | 股份 |
| Blue Trust, Inc. | $486619 | 69122 | 0.49% | 股份 |
| BANK OF AMERICA CORP /DE/ | $406292 | 57712 | 0.41% | 股份 |
| BANK OF MONTREAL /CAN/ | $386806 | 54944 | 0.39% | 股份 |
| Private Capital Management, LLC | $352000 | 50000 | 0.36% | 股份 |
| Nuveen, LLC | $340377 | 48349 | 0.35% | 股份 |
| MORGAN STANLEY | $329993 | 46874 | 0.33% | 股份 |
| Meridian Wealth Management, LLC | $306944 | 43600 | 0.31% | 股份 |
| Ballentine Partners, LLC | $288725 | 41012 | 0.29% | 股份 |
| CATALYST FINANCIAL PARTNERS LLC | $270737 | 38457 | 0.27% | 股份 |
| WELLS FARGO & COMPANY/MN | $259973 | 36928 | 0.26% | 股份 |
| DEUTSCHE BANK AG\ | $255714 | 36323 | 0.26% | 股份 |
| AWM Investment Company, Inc. | $253440 | 36000 | 0.26% | 股份 |
| World Investment Advisors | $250321 | 36975 | 0.25% | 股份 |
| HSBC HOLDINGS PLC | $244702 | 34224 | 0.25% | 股份 |
| RHUMBLINE ADVISERS | $221471 | 31460 | 0.22% | 股份 |
| ROYAL BANK OF CANADA | $172000 | 24322 | 0.17% | 股份 |
| Creative Planning | $169946 | 24140 | 0.17% | 股份 |
| UBS Group AG | $160857 | 22849 | 0.16% | 股份 |
| MetLife Investment Management, LLC | $143475 | 20380 | 0.15% | 股份 |
| Invesco Ltd. | $138716 | 19704 | 0.14% | 股份 |
| Brevan Howard Capital Management LP | $126973 | 18036 | 0.13% | 股份 |
| CITIGROUP INC | $121594 | 17272 | 0.12% | 股份 |
| HighTower Advisors, LLC | $120208 | 17075 | 0.12% | 股份 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $118800 | 16875 | 0.12% | 股份 |
| Cornerstone Wealth Management, LLC | $114400 | 16250 | 0.12% | 股份 |
| RAYMOND JAMES FINANCIAL INC | $111169 | 15791 | 0.11% | 股份 |
公司内部人士 21 位内幕人士 · 4 位高管 · 6 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Dietrich John Pauls | President & CEO | 2026年8月10日 A | 128791 | 0 | 0 | $0 |
| Scott Kellen | CFO & Secretary | 2026年6月1日 A | 32290 | 0 | 0 | $0 |
| Julie Krop | Chief Medical Officer | 2026年6月1日 A | · | 0 | 0 | $0 |
| David J. Wambeke | Chief Business Officer | 2025年6月1日 A | 527114 | 0 | 0 | $0 |
| Charles Pauling Semba | 董事 | 2026年6月1日 A | 47963 | 0 | 0 | $0 |
| James T. Parsons | 董事 | 2026年6月1日 A | 97949 | 0 | 0 | $0 |
| Randall Michael Giuffre | 董事 | 2026年6月1日 A | 398587 | 0 | 0 | $0 |
| Tanya Lewis | 董事 | 2026年6月1日 A | · | 0 | 0 | $0 |
| Richard D. Pilnik | 董事 | 2025年4月7日 M | 312995 | 0 | 0 | $0 |
| Richard Jacinto II | 10% 所有者 | 2025年7月23日 P | 4958823 | 0 | 0 | $0 |
| Daniel J. O'Connor | · | 2026年6月1日 A | · | 0 | 0 | $0 |
| Richard Kuntz | · | 2026年6月1日 A | 24210 | 0 | 0 | $0 |
| Dominic R Cundari | · | 2024年6月1日 A | · | 0 | 0 | $0 |
| Masuoka K. Lorianne | · | 2024年1月22日 A | · | 0 | 0 | $0 |
| Julie Vanorsdel Daves | · | 2023年6月1日 A | · | 0 | 0 | $0 |
| Kirsten L Gruis | · | 2023年6月1日 A | · | 0 | 0 | $0 |
| Amy L. Burroughs | · | 2023年1月3日 A | 73288 | 0 | 0 | $0 |
| Harry W Alcorn JR | · | 2021年9月15日 P | 43582 | 0 | 0 | $0 |
| Sydney A. Gilman | · | 2021年7月28日 A | · | 0 | 0 | $0 |
| Zhenyu Xiao | · | 2019年6月24日 A | 7100 | 0 | 0 | $0 |
| Todd A. Verdoorn | · | 2019年6月24日 A | 2000 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 8 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| IWC · iShares Trust | 0.06% | 124465 SH | 2026年9月11日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.02% | 38896 SH | 2026年8月19日 | 每日 |
| IWO · iShares Trust | 0.02% | 344141 SH | 2026年9月11日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 210368 SH | 2026年8月19日 | 每日 |
| IWM · iShares Trust | 0.01% | 916250 SH | 2026年9月11日 | 每日 |
| RSSL · Global X Funds | 0.01% | 17486 NS | 2026年7月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 355523 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 2407 SH | 2026年8月19日 | 每日 |
DMAC 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 11 位分析师
买入
中位数目标
$13.00
+58.0%
2 18.2%
强烈买入
8 72.7%
买入
1 9.1%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
4 位分析师 · 2026-09-30平均目标 $15.50 +88.3%
← 低于所有目标
当前价格 $8.23
最低$11.00
平均值$15.50
最高$25.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| DMAC | $428M | · | · | · | -78.7% | · |
| PROK | · | · | 1075.0% | -7725.2% | 6.9% | · |
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | · |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | · |
| OVID | $212M | -4.0 | 1181.3% | -240.1% | -18.7% | · |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | · |
| TECX | $391M | -5.2 | · | · | -27.7% | · |
| SPRY | $1.16B | -6.7 | -5.5% | -203.3% | -111.8% | · |
| MYGN | $575M | -1.6 | -1.6% | -44.4% | -96.8% | 69.9% |
| GALT | $271M | -8.7 | · | · | 25.0% | · |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 10, 2026 申报